Likewise, reviews of multi-national cohort studies performed before awareness of this IGF1R SNP contribution concluded that the general breast cancer risk-reducing impact of preeclampsia is modest (10–20%), if present at all [10]. This evidence concerns the gene IGF1R and breast carcinoma.